- Home
- HOUS vs IMTX Comparison
HOUS vs IMTX Comparison
Compare HOUS & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HOUS | IMTX |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2006 | N/A |
Fundamental Metrics
Financial Performance| Metric | HOUS | IMTX |
|---|---|---|
| Price | $14.33 | $10.06 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $13.33 | ★ $19.25 |
| AVG Volume (30 Days) | ★ 1.9M | 646.5K |
| Earning Date | 11-04-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $5,874,000,000.00 | $99,445,031.00 |
| Revenue This Year | $6.82 | N/A |
| Revenue Next Year | $6.94 | $24.39 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 5.27 | N/A |
| 52 Week Low | $2.71 | $3.30 |
| 52 Week High | $14.97 | $12.41 |
Technical Indicators
Market Signals| Indicator | HOUS | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 67.58 | 48.99 |
| Support Level | $14.05 | $9.75 |
| Resistance Level | $14.97 | $12.41 |
| Average True Range (ATR) | 0.68 | 0.80 |
| MACD | -0.08 | -0.08 |
| Stochastic Oscillator | 78.39 | 11.09 |
Price Performance
Historical ComparisonAbout HOUS Anywhere Real Estate Inc.
Anywhere Real Estate Inc operates in residential real estate, focusing on brokerage, relocation, title, settlement businesses, and mortgage and title insurance ventures. It supports approximately 1 million home sale sides annually. Brands include Better Homes and Gardens, CENTURY 21, Coldwell Banker, Corcoran, ERA, and Sotheby's International Realty. Revenue comes mainly from existing home transactions. Operations are segmented into Anywhere Brands (franchises), Anywhere Advisors (owned brokerage), and Anywhere Integrated Services (title and settlement).
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.